Hepatitis C Treatment Options in 2023
From direct-acting antiviral medications and interferon-based therapies, find out the current treatment options for hepatitis C in 2023.
Continue reading »From direct-acting antiviral medications and interferon-based therapies, find out the current treatment options for hepatitis C in 2023.
Continue reading »Find out some causes of hepatitis C treatment failure as well as steps you can take if your hep C treatment isn't working.
Continue reading »Here are some options to consider, including oral antiviral medications, for treating hepatitis C in 2022.
Continue reading »Recent research suggests that shortening your course of hepatitis C treatment may increase your risk of relapse.
Continue reading »Learn about the recommendations for the treatment of HCV in 2021. While we are still looking for a hepatitis C vaccine and pushing for earlier screening and identification of those infected, there are 4 diet and lifestyle changes you can make now to help heal your liver.
Continue reading »Discover what it means to treat hepatitis C with the 'Netflix' model, which states are participating, and if the payment model is beneficial.
Continue reading »A uniquely effective and affordable cure against Hepatitis C (HCV) has been unearthed by the non-profit Drugs for Neglected Disease Initiative (DNDI) and a for profit Egyptian company called Pharco Pharmaceuticals. The wonderful formulation is a combination of the drugs sofosbuvir and ravidasvir and is currently undergoing a multicenter phase III trial (STORM-C).
Continue reading »As we enter a new decade, take a look back at the progress made in 2019 with Hepatitis C drugs, as well as the awareness and elimination goals planned for the virus in 2020 and beyond.
Continue reading »Leading research indicates vastly improved outcomes for HCV and liver cancer patients using all-oral direct-acting antiviral treatments.
Continue reading »The New Year is upon us and already there’s no shortage of Hepatitis C treatment news. Several big announcements in mid-2018 set the stage for generic versions of many Hepatitis C drugs to hit the market by early 2019.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window